Day: February 11, 2021
FORT LAUDERDALE, Fla., Feb. 11, 2021 (GLOBE NEWSWIRE) — LMP Automotive Holdings, Inc. (NASDAQ: LMPX) (the “Company” or “LMP”), an e-commerce and facilities-based platform for consumers who desire to buy, sell, subscribe to or finance pre-owned and new automobiles, today announced it has engaged KPMG LLP (“KPMG”) as its independent auditor for the Company’s fiscal year ending December 31, 2021 and is providing outlook and updates on its M&A, corporate and other activities.Evan Bernstein, LMP’s Chief Financial Officer, stated, “Given LMP’s M&A and capital markets strategies and the upcoming closings of our stage 1 acquisitions, the Company has decided it was an appropriate time to transition to a Big 4 accounting firm. LMP has selected KPMG based on its industry expertise, diversity, and reach. The upcoming...
Energy Technology Executive Elected to Tyson Foods Board of Directors
Written by Customer Service on . Posted in Public Companies.
SPRINGDALE, Ark., Feb. 11, 2021 (GLOBE NEWSWIRE) — Maria Claudia Borras has been elected to the board of directors of Tyson Foods (NYSE: TSN), the company announced today.Borras is executive vice president of Oilfield Services at Baker Hughes, an international energy technology company, where she leads the company’s largest business segment with more than 26,000 employees and operations in 120 countries. She has served in other executive and management roles at Baker Hughes and was also previously chief commercial officer for GE Oil and Gas.During her more than 25-year career, Borras has been actively engaged in industrial manufacturing and services and complex project environments, while successfully leading organizational transformations, growing market share and helping deliver sustainable results.“We’re pleased to welcome Maria...
Omega Flex, Inc. Announces Fourth Quarter 2020 Earnings
Written by Customer Service on . Posted in Public Companies.
EXTON, Pa., Feb. 11, 2021 (GLOBE NEWSWIRE) —Kevin R. Hoben, Chairman and CEO, announced that the Company’s net sales for 2020 and 2019 were $105,796,000 and $111,360,000, respectively, decreasing 5.0%. The Company’s sales volume for the year decreased as a result of restrictions imposed in response to the Covid-19 pandemic during the second quarter of 2020. Sales generally rose after reaching the lowest point in April 2020, with several months exceeding sales results from the prior year.Net sales for the three months ended December 31, 2020 were strong, increasing 6.4% over the fourth quarter of 2019. The Company’s net income for 2020 was $19,910,000 compared to $17,286,000 during 2019, increasing $2,624,000 or 15.2%.The growth in net income for the year is driven by decreases in several atypical SG&A items identified during...
Datadog Announces Fourth Quarter and Full Year 2020 Results
Written by Customer Service on . Posted in Public Companies.
Fourth quarter revenue grew 56% year-over-year to $178 millionStrong growth of larger customers, with 97 $1 million+ ARR customers, up from 50 a year agoAnnounced an agreement to acquire Sqreen, a SaaS based security platform, and the acquisition of Timber Technologies, the makers of an observability data management productLaunched the general availability of Incident Management; enhanced Security with two new beta offeringsNEW YORK, Feb. 11, 2021 (GLOBE NEWSWIRE) — Datadog, Inc. (NASDAQ:DDOG), the monitoring and security platform for cloud applications, today announced financial results for its fourth quarter ended December 31, 2020.“We are pleased with our strong results for the fourth quarter, which demonstrated continued high growth at scale.” said Olivier Pomel, co-founder and CEO of Datadog. “The quarter closes a strong year...
BridgeBio Pharma, Inc. Announces Launch of Secondary Offering of Common Stock
Written by Customer Service on . Posted in Public Companies.
PALO ALTO, Calif., Feb. 11, 2021 (GLOBE NEWSWIRE) — BridgeBio Pharma, Inc. (Nasdaq: BBIO) (the “Company,” “we” or “BridgeBio”) announced today the launch of a secondary public offering of 3,000,000 shares of its common stock by selling stockholder KKR Genetic Disorder L.P. The selling stockholder has also granted the underwriters a 30-day option to purchase up to 450,000 additional shares of common stock. All shares are being sold by KKR Genetic Disorder L.P. The Company is not selling any shares and will not receive any of the proceeds of the offering.Goldman Sachs & Co. LLC is acting as the sole book-running manager and KKR Capital Markets LLC and Raymond James & Associates, Inc. are acting as co-managers for the offering.The securities described above are being offered pursuant to an automatic shelf registration statement...
SPS Commerce Reports Fourth Quarter and Full Year 2020 Financial Results
Written by Customer Service on . Posted in Public Companies.
MINNEAPOLIS, Feb. 11, 2021 (GLOBE NEWSWIRE) — SPS Commerce, Inc. (Nasdaq: SPSC), a leader in retail cloud services, today announced financial results for the fourth quarter and full year ended December 31, 2020.Revenue was $83.3 million in the fourth quarter of 2020, compared to $72.7 million in the fourth quarter of 2019, reflecting 15% growth in revenue from the fourth quarter of 2019. Recurring revenue grew 15% from the fourth quarter of 2019.Net income in the fourth quarter of 2020 was $13.5 million or $0.37 per diluted share, compared to net income of $9.2 million or $0.25 per diluted share, in the fourth quarter of 2019. Non-GAAP net income per diluted share was $0.40, compared to non-GAAP net income per diluted share of $0.35 in the fourth quarter of 2019. Adjusted EBITDA for the fourth quarter of 2020 increased 22% to $23.0...
Mohawk Industries Reports Q4 Results
Written by Customer Service on . Posted in Public Companies.
CALHOUN, Ga., Feb. 11, 2021 (GLOBE NEWSWIRE) — Mohawk Industries, Inc. (NYSE: MHK) today announced a 2020 fourth quarter net profit of $248 million and diluted earnings per share (EPS) of $3.49. Adjusted net earnings were $252 million, and EPS was $3.54, excluding restructuring, acquisition and other charges. Net sales for the fourth quarter of 2020 were $2.6 billion, an increase of 9.0% as reported and 5.5% on a constant currency and days basis. For the fourth quarter of 2019, net sales were $2.4 billion, net earnings were $265 million and EPS was $3.68, which included a one-time tax benefit. Adjusted net earnings were $162 million, and EPS was $2.25, excluding restructuring, acquisition and other charges in addition to the one-time tax benefit.For the twelve months ending December 31, 2020, net earnings and EPS were $516 million...
Nasdaq Completes Acquisition of Verafin
Written by Customer Service on . Posted in Mergers And Acquisitions.
NEW YORK and ST. JOHN’S, Newfoundland and Labrador, Feb. 11, 2021 (GLOBE NEWSWIRE) — Nasdaq, Inc. (Nasdaq: NDAQ), a global technology company, announced today the completion of its acquisition of Verafin, an industry pioneer in anti-financial crime management solutions. The agreement to acquire Verafin was announced on November 19, 2020.The transaction accelerates Nasdaq’s ongoing evolution into a leading SaaS technology provider and significantly strengthens its existing regulatory and anti-financial crime solutions. Looking ahead, Verafin’s capabilities will be expanded to service a global ecosystem of Tier-1 and Tier-2 banks and broker-dealers, many of which currently leverage Nasdaq’s technology to detect market manipulation and abuse.“At Nasdaq, we believe that fair, secure and transparent markets are vital to creating strong...
Bioanalytical Systems, Inc., doing business as Inotiv, Appoints Greg Beattie as Chief Operating Officer
Written by Customer Service on . Posted in Public Companies.
WEST LAFAYETTE, Ind., Feb. 11, 2021 (GLOBE NEWSWIRE) — Bioanalytical Systems, Inc. (NASDAQ:BASI) (the “Company”, “We”, “Our” or “Inotiv”), doing business as Inotiv, a leading provider of nonclinical and analytical contract research services, today announced the appointment of Greg Beattie as Chief Operating Officer of the Company, effective February 15, 2021.Mr. Beattie brings more than 30 years of contract research experience to the Company, including more than two decades in operational leadership roles at Charles River Laboratories, where he drove growth and profitability across multiple business units. During his career at Charles River Laboratories, Mr. Beattie held Corporate Vice President positions leading business units within all three of Charles River Laboratories’ segments of operations (Discovery and Safety Assessment,...
Myriad Genetics to Participate in Multiple Upcoming Health and Technology Conferences
Written by Customer Service on . Posted in Public Companies.
SALT LAKE CITY, Feb. 11, 2021 (GLOBE NEWSWIRE) — Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in genetic testing and precision medicine, announced today that it will participate at multiple upcoming health and technology conferences, sharing insights on how the company is intensifying its focus on serving patients and healthcare providers in Women’s Health, Oncology and Mental Health.Paul J. Diaz, president and CEO at Myriad Genetics, and R. Bryan Riggsbee, CFO, will participate in a fireside chat at the BTIG Virtual MedTech, Digital Health, Life Science & Diagnostic Tools Conference on February 19 at 10:30 a.m. EST.On February 24, 2021, Mr. Riggsbee will participate in a fireside chat at the Leerink Global Healthcare Conference at 5:00 p.m. EST.On March 2, 2021, Mr. Diaz will participate in a fireside chat at the Cowen Annual...